Cancer Treatment Reviews
Volume 31, Supplement 2 , Pages S10-S16, 2005

Fulvestrant (‘Faslodex’): Clinical experience from the Compassionate Use Programme

  • Guenther G. Steger

      Affiliations

    • Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, 18-20 Währinger Gürtel, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 140 400 5466; fax: +43 140 400 6081.
    • ,
  • Maya Gips

      Affiliations

    • Hadassah Medical Center, Jerusalem, Israel
    • ,
  • Sergio D. Simon

      Affiliations

    • Hospital Albert Einstein, São Paulo, Brazil
    • ,
  • Ana Lluch

      Affiliations

    • Hospital Clinico de Valencia, Valencia, Spain
    • ,
  • Jefferson Vinholes

      Affiliations

    • Santa Casa Hospital, Porto Alegre, Brazil
    • ,
  • Bella Kaufman

      Affiliations

    • The Chaim Sheba Medical Center, Tel-Hashomer, Israel
    • ,
  • Andrew Wardley

      Affiliations

    • Christie Hospital NHS Trust, Manchester, UK
    • ,
  • Louis Mauriac

      Affiliations

    • Institut Bergonié, Centre Régional de Lutte Contre le Cancer de Bordeaux et du Sud-Ouest, Bordeaux, France

published online 04 October 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(05)00141-6

doi:10.1016/j.ctrv.2005.08.009

Cancer Treatment Reviews
Volume 31, Supplement 2 , Pages S10-S16, 2005

Article Tools

* Image Usage & Resolution